Clinical Trial Update: Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study of the human anti-TNF monoclonal antibody D2E7 in active rheumatoid arthritis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• D2E7

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED